Cost Analysis Of Treatment Success To Achieve A Clinically Relevant Composite Endpoint For Patients With Type-2 Diabetes On Liraglutide Or Other Antidiabetic Therapies In A Chinese Setting

May 1, 2013, 00:00
10.1016/j.jval.2013.03.802
https://www.valueinhealthjournal.com/article/S1098-3015(13)00873-5/fulltext
Title : Cost Analysis Of Treatment Success To Achieve A Clinically Relevant Composite Endpoint For Patients With Type-2 Diabetes On Liraglutide Or Other Antidiabetic Therapies In A Chinese Setting
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)00873-5&doi=10.1016/j.jval.2013.03.802
First page : A160
Section Title : Diabetes/Endocrine Disorders
Open access? : No
Section Order : 345
Categories :
Tags :
Regions :
ViH Article Tags :